Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Asensus Surgical grows Senhance Surgical procedures by 44%, gives guidance for 2022

Asensus Surgical grows Senhance Surgical procedures by 44%, gives guidance for 2022

Asensus Surgical (NYSE:ASXC) Inc Executive Vice President and CFO Shameze Rampertab tells Proactive the Durham, North Carolina-based medical technology company performed over 2,100 Senhance Surgical procedures around the world in 2021, representing an increase in 44% compared to 2020.

The Senhance Surgical System performs digital laparoscopy surgeries to increase surgeon control and reduce surgical variability. For 2022, the group has given guidance of an expected 10-12 installations.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK